Correlation Between Puma Biotechnology and Veracyte

Can any of the company-specific risk be diversified away by investing in both Puma Biotechnology and Veracyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Puma Biotechnology and Veracyte into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Puma Biotechnology and Veracyte, you can compare the effects of market volatilities on Puma Biotechnology and Veracyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Puma Biotechnology with a short position of Veracyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Puma Biotechnology and Veracyte.

Diversification Opportunities for Puma Biotechnology and Veracyte

0.7

Correlation Coefficient

Puma Biotechnology  Veracyte

Poor diversification

The 3 months correlation between Puma and Veracyte is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and Veracyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Veracyte and Puma Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Puma Biotechnology are associated (or correlated) with Veracyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Veracyte has no effect on the direction of Puma Biotechnology i.e., Puma Biotechnology and Veracyte go up and down completely randomly.

Pair Corralation between Puma Biotechnology and Veracyte

Given the investment horizon of 90 days Puma Biotechnology is expected to generate 1.96 times less return on investment than Veracyte. In addition to that, Puma Biotechnology is 1.33 times more volatile than Veracyte. It trades about 0.11 of its total potential returns per unit of risk. Veracyte is currently generating about 0.28 per unit of volatility. If you would invest  3,671  in Veracyte on September 18, 2024 and sell it today you would earn a total of  553.00  from holding Veracyte or generate 15.06% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Puma Biotechnology  vs.  Veracyte

Puma Biotechnology

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Puma Biotechnology are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Puma Biotechnology demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Veracyte

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Veracyte are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent basic indicators, Veracyte unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Puma Biotechnology and Veracyte

The main advantage of trading using opposite Puma Biotechnology and Veracyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Puma Biotechnology position performs unexpectedly, Veracyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Veracyte will offset losses from the drop in Veracyte's long position.

The idea behind Puma Biotechnology and Veracyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.